{"schema_version":"secwatch.filing_event.v1","accession":"0000914475-25-000186","form_type":"8-K","ticker":"NBIX","cik":"0000914475","company_name":"NEUROCRINE BIOSCIENCES INC","filed_at":"2025-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.589276+00:00","generated_at":"2026-05-16T17:30:24.349853+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Neurocrine extends former CMO Eiry Roberts as Strategic Advisor through Dec 31, 2026","bullets":["Roberts, former CMO, transitioned to Strategic Advisor effective June 2, 2025; term extended to Dec 31, 2026 (Amended Employment Agreement).","Base salary of $731,400 through Dec 31, 2025; future salary to be set by Compensation Committee thereafter.","Annual cash incentive bonus target 60% of base pay for 2025 and 2026, subject to corporate and individual goals.","Employment agreement expires Dec 31, 2026 unless earlier terminated; no severance upon natural expiration."],"urls":{"canonical":"https://secwatch.observer/filing/0000914475-25-000186","json":"https://secwatch.observer/filing/0000914475-25-000186.json","markdown":"https://secwatch.observer/filing/0000914475-25-000186.md","text":"https://secwatch.observer/filing/0000914475-25-000186.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/0000914475-25-000186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/nbix-20251121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:30:24.349853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}